Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5 Pt 2
|
pubmed:dateCreated |
1986-2-28
|
pubmed:abstractText |
Minimal inhibitory concentrations (MICs) of imipenem were evaluated by agar dilution for 2 895 bacterial strains isolated in 9 hospitals. Imipenem proved highly active against Enterobacteriaceae, with an MIC less than or equal to 0.25 for 63% of the 1 556 tested strains, less than or equal to 1 for 89.6% and less than or equal to 4 for 99%. The different groups of Enterobacteriaceae exhibited similar mode MICs (0.12 to 0.25), with the exception of Serratia (0.25-0.5), P. mirabilis (0.5), indole-positive Proteus (2), and Providencia (1). MICs of most cefotaxime-resistant strains were within the susceptibility range. Imipenem also exhibited satisfactory activity against P. aeruginosa (mode MIC 1-2) and Acinetobacter sp. (mode MIC: 0.25-0.5). MICs ranged from 0.03 to 4 (mode MIC: 0.5) for Haemophilus sp. and 0.25 to 1 for Gonococci, regardless of beta-lactamase-production status. MICs for Meningococci were less than or equal to 0,06. Methicillin-susceptible Staphylococci had low MICs, ranging from 0.008 to 0.5 (mode MIC : 0.016); MICs for methicillin-resistant strains varied widely, from 0.016 to 64, and were higher after incubation at 30 degrees C. Streptococci, except for Enterococci, and Pneumococci were highly susceptible (usually 0.008-0.03); MICs for Enterococci varied from 0,12 to 32 (mode MIC: 1-2). Except for four C. difficile strains, all tested anaerobic strains were inhibited by concentrations less than or equal to 1 (mode MICs: 0.06 for C. perfringens and 0.03 for B. fragilis).
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0369-8114
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
487-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3911142-Acinetobacter,
pubmed-meshheading:3911142-Aeromonas,
pubmed-meshheading:3911142-Bacteria,
pubmed-meshheading:3911142-Bacteroides fragilis,
pubmed-meshheading:3911142-Clostridium,
pubmed-meshheading:3911142-Dose-Response Relationship, Drug,
pubmed-meshheading:3911142-Enterobacteriaceae,
pubmed-meshheading:3911142-Haemophilus,
pubmed-meshheading:3911142-Hospitals,
pubmed-meshheading:3911142-Imipenem,
pubmed-meshheading:3911142-Microbial Sensitivity Tests,
pubmed-meshheading:3911142-Neisseria,
pubmed-meshheading:3911142-Pseudomonas,
pubmed-meshheading:3911142-Staphylococcus aureus,
pubmed-meshheading:3911142-Streptococcus,
pubmed-meshheading:3911142-Thienamycins
|
pubmed:year |
1985
|
pubmed:articleTitle |
[Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|